Schramm S - Search Results

1

HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.

Rohn H, Michita RT, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. Rohn H, et al. Among authors: schramm s. Cells. 2019 Aug 7;8(8):847. doi: 10.3390/cells8080847. Cells. 2019. PMID: 31394776 Free PMC article.

2

The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.

König L, Kasimir-Bauer S, Hoffmann O, Bittner AK, Wagner B, Manvailer LF, Schramm S, Bankfalvi A, Giebel B, Kimmig R, Horn PA, Rebmann V. König L, et al. Among authors: schramm s. Hum Immunol. 2016 Sep;77(9):791-9. doi: 10.1016/j.humimm.2016.01.002. Epub 2016 Jan 12. Hum Immunol. 2016. PMID: 26796737

3

HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia.

Wagner B, da Silva Nardi F, Schramm S, Kraemer T, Celik AA, Dürig J, Horn PA, Dührsen U, Nückel H, Rebmann V. Wagner B, et al. Among authors: schramm s. Cancer. 2017 Mar 1;123(5):814-823. doi: 10.1002/cncr.30427. Epub 2016 Nov 2. Cancer. 2017. PMID: 27859015 Free article.

4

A Valine Mismatch at Position 129 of MICA Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas⁻Kidney Transplantation Recipients.

Michita RT, Chies JAB, Schramm S, Horn PA, Heinemann FM, Wunsch A, Viebahn R, Schenker P, Rebmann V. Michita RT, et al. Among authors: schramm s. Int J Mol Sci. 2018 Sep 4;19(9):2618. doi: 10.3390/ijms19092618. Int J Mol Sci. 2018. PMID: 30181474 Free PMC article.

5

HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant.

Rohn H, Schwich E, Tomoya Michita R, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. Rohn H, et al. Among authors: schramm s. Hum Immunol. 2020 Apr;81(4):141-146. doi: 10.1016/j.humimm.2019.09.011. Epub 2019 Oct 31. Hum Immunol. 2020. PMID: 31679637

6

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma.

Ugurel S, Schadendorf D, Horny K, Sucker A, Schramm S, Utikal J, Pföhler C, Herbst R, Schilling B, Blank C, Becker JC, Paschen A, Zimmer L, Livingstone E, Horn PA, Rebmann V. Ugurel S, et al. Among authors: schramm s. Ann Oncol. 2020 Jan;31(1):144-152. doi: 10.1016/j.annonc.2019.09.005. Ann Oncol. 2020. PMID: 31912789 Free article.

7

Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma.

Wagner B, Dührsen U, Hüttmann A, Nückel H, Michita RT, Rohn H, Schramm S, Horn PA, Rebmann V. Wagner B, et al. Among authors: schramm s. Cancers (Basel). 2020 Nov 18;12(11):3429. doi: 10.3390/cancers12113429. Cancers (Basel). 2020. PMID: 33218185 Free PMC article.

8

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.

Rohn H, Lang C, Schramm S, Heinemann FM, Trilling M, Gäckler A, Witzke O, Horn PA, Rebmann V. Rohn H, et al. Among authors: schramm s. J Immunol Res. 2022 May 12;2022:4829227. doi: 10.1155/2022/4829227. eCollection 2022. J Immunol Res. 2022. PMID: 35600048 Free PMC article.

9

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.

Rohn H, Schramm S, Pansikaki K, Jansen S, Hendriks C, Platte M, Konik MJ, Dolff S, Wilde B, Kordelas L, Trilling M, Krawczyk A, Horn PA, Witzke O, Rebmann V. Rohn H, et al. Among authors: schramm s. Hum Immunol. 2023 Aug;84(8):393-400. doi: 10.1016/j.humimm.2023.03.002. Epub 2023 Mar 14. Hum Immunol. 2023. PMID: 36925435 Free PMC article.

10

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.

Hoffmann O, Wormland S, Bittner AK, Hölzenbein J, Schwich E, Schramm S, Rohn H, Horn PA, Kimmig R, Kasimir-Bauer S, Rebmann V. Hoffmann O, et al. Among authors: schramm s. Front Immunol. 2023 May 22;14:1188030. doi: 10.3389/fimmu.2023.1188030. eCollection 2023. Front Immunol. 2023. PMID: 37283737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page